Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals All requirements for closing the deal, including shareholders’ approval and ending of the ...
28m
OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback